Tat28-35SL8-specific CD8+ T lymphocytes are more effective than Gag181-189CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay

John T. Loffredo, Eva G. Rakasz, Juan Pablo Giraldo, Sean P. Spencer, Kelly K. Grafton, Sarah R. Martin, Gnankang Napoé, Levi J. Yant, Nancy A. Wilson, David Watkins

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Epitope-specific CD8+ T lymphocytes may play an important role in controlling human immunodeficiency virus (HIV)/simian immunodeficiency virus replication. Unfortunately, standard cellular assays do not measure the antiviral efficacy (the ability to suppress virus replication) of CD8 + T lymphocytes. Certain epitope-specific CD8+ T lymphocytes may be better than others at suppressing viral replication. We compared the antiviral efficacy of two immunodominant CD8+ T lymphocyte responses-Tat28-35SL8 and Gag181-189CM9-by using a functional in vitro assay. Viral suppression by Tat-specific CD8 + T lymphocytes was consistently greater than that of Gag-specific CD8+ T lymphocytes. Such differences in antigen-specific CD8 +-T-Iymphocyte efficacy may be important for selecting CD8 + T lymphocyte epitopes for inclusion in future HIV vaccines.

Original languageEnglish
Pages (from-to)14986-14991
Number of pages6
JournalJournal of Virology
Volume79
Issue number23
DOIs
StatePublished - Dec 1 2005
Externally publishedYes

Fingerprint

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Virus Replication
virus replication
T-lymphocytes
T-Lymphocytes
assays
epitopes
Human immunodeficiency virus
Antiviral Agents
Epitopes
HIV
CD8 Antigens
T-Lymphocyte Epitopes
In Vitro Techniques
Vaccines
vaccines
antigens

ASJC Scopus subject areas

  • Immunology

Cite this

Tat28-35SL8-specific CD8+ T lymphocytes are more effective than Gag181-189CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay. / Loffredo, John T.; Rakasz, Eva G.; Giraldo, Juan Pablo; Spencer, Sean P.; Grafton, Kelly K.; Martin, Sarah R.; Napoé, Gnankang; Yant, Levi J.; Wilson, Nancy A.; Watkins, David.

In: Journal of Virology, Vol. 79, No. 23, 01.12.2005, p. 14986-14991.

Research output: Contribution to journalArticle

Loffredo, John T. ; Rakasz, Eva G. ; Giraldo, Juan Pablo ; Spencer, Sean P. ; Grafton, Kelly K. ; Martin, Sarah R. ; Napoé, Gnankang ; Yant, Levi J. ; Wilson, Nancy A. ; Watkins, David. / Tat28-35SL8-specific CD8+ T lymphocytes are more effective than Gag181-189CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay. In: Journal of Virology. 2005 ; Vol. 79, No. 23. pp. 14986-14991.
@article{afb7ea03ed974a09ae06d6679eeceaae,
title = "Tat28-35SL8-specific CD8+ T lymphocytes are more effective than Gag181-189CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay",
abstract = "Epitope-specific CD8+ T lymphocytes may play an important role in controlling human immunodeficiency virus (HIV)/simian immunodeficiency virus replication. Unfortunately, standard cellular assays do not measure the antiviral efficacy (the ability to suppress virus replication) of CD8 + T lymphocytes. Certain epitope-specific CD8+ T lymphocytes may be better than others at suppressing viral replication. We compared the antiviral efficacy of two immunodominant CD8+ T lymphocyte responses-Tat28-35SL8 and Gag181-189CM9-by using a functional in vitro assay. Viral suppression by Tat-specific CD8 + T lymphocytes was consistently greater than that of Gag-specific CD8+ T lymphocytes. Such differences in antigen-specific CD8 +-T-Iymphocyte efficacy may be important for selecting CD8 + T lymphocyte epitopes for inclusion in future HIV vaccines.",
author = "Loffredo, {John T.} and Rakasz, {Eva G.} and Giraldo, {Juan Pablo} and Spencer, {Sean P.} and Grafton, {Kelly K.} and Martin, {Sarah R.} and Gnankang Napo{\'e} and Yant, {Levi J.} and Wilson, {Nancy A.} and David Watkins",
year = "2005",
month = "12",
day = "1",
doi = "10.1128/JVI.79.23.14986-14991.2005",
language = "English",
volume = "79",
pages = "14986--14991",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - Tat28-35SL8-specific CD8+ T lymphocytes are more effective than Gag181-189CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay

AU - Loffredo, John T.

AU - Rakasz, Eva G.

AU - Giraldo, Juan Pablo

AU - Spencer, Sean P.

AU - Grafton, Kelly K.

AU - Martin, Sarah R.

AU - Napoé, Gnankang

AU - Yant, Levi J.

AU - Wilson, Nancy A.

AU - Watkins, David

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Epitope-specific CD8+ T lymphocytes may play an important role in controlling human immunodeficiency virus (HIV)/simian immunodeficiency virus replication. Unfortunately, standard cellular assays do not measure the antiviral efficacy (the ability to suppress virus replication) of CD8 + T lymphocytes. Certain epitope-specific CD8+ T lymphocytes may be better than others at suppressing viral replication. We compared the antiviral efficacy of two immunodominant CD8+ T lymphocyte responses-Tat28-35SL8 and Gag181-189CM9-by using a functional in vitro assay. Viral suppression by Tat-specific CD8 + T lymphocytes was consistently greater than that of Gag-specific CD8+ T lymphocytes. Such differences in antigen-specific CD8 +-T-Iymphocyte efficacy may be important for selecting CD8 + T lymphocyte epitopes for inclusion in future HIV vaccines.

AB - Epitope-specific CD8+ T lymphocytes may play an important role in controlling human immunodeficiency virus (HIV)/simian immunodeficiency virus replication. Unfortunately, standard cellular assays do not measure the antiviral efficacy (the ability to suppress virus replication) of CD8 + T lymphocytes. Certain epitope-specific CD8+ T lymphocytes may be better than others at suppressing viral replication. We compared the antiviral efficacy of two immunodominant CD8+ T lymphocyte responses-Tat28-35SL8 and Gag181-189CM9-by using a functional in vitro assay. Viral suppression by Tat-specific CD8 + T lymphocytes was consistently greater than that of Gag-specific CD8+ T lymphocytes. Such differences in antigen-specific CD8 +-T-Iymphocyte efficacy may be important for selecting CD8 + T lymphocyte epitopes for inclusion in future HIV vaccines.

UR - http://www.scopus.com/inward/record.url?scp=27744525304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744525304&partnerID=8YFLogxK

U2 - 10.1128/JVI.79.23.14986-14991.2005

DO - 10.1128/JVI.79.23.14986-14991.2005

M3 - Article

VL - 79

SP - 14986

EP - 14991

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 23

ER -